资讯

Camurus AB: CHMP recommends approval of Oczyesa for treatment of acromegaly in the EU
Camurus (NASDAQ STO: CAMX) today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted ...
CHMP recommends approval of Oczyesa® for treatment of acromegaly in the EU
Camurus (NASDAQ STO: CAMX) today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) ...
The Guardian Nigeria4 天
Fighting Back Against Type 2 Diabetes
Type 2 diabetes is a global health concern, especially in low- and middle-income countries, where its prevalence is rapidly increasing ...